Cargando…
Long-term benefit from immune modulation and anti-inflammatory treatment in metastatic mesothelioma
A 64 year old male heating engineer was investigated for a persistent cough and found to have epithelioid mesothelioma with pleural effusion, lung nodules and increased thoracic lymph nodes. He declined standard of care treatment following his own research and he was enrolled in a named patient prog...
Autores principales: | Dalgleish, Angus G., McLean, Emma, Patel, Nirav, Rahman, Najib |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879978/ https://www.ncbi.nlm.nih.gov/pubmed/31788420 http://dx.doi.org/10.1016/j.rmcr.2019.100971 |
Ejemplares similares
-
The role of immune modulation and anti-inflammatory agents in the management of prostate cancer: A case report of six patients
por: Dalgleish, Angus G., et al.
Publicado: (2022) -
Metastatic mesothelioma to the thyroid
por: Rao, Sarika N., et al.
Publicado: (2014) -
A heat-killed preparation of mycobacterium obuense can reduce metastatic burden in vivo
por: Fowler, Daniel, et al.
Publicado: (2014) -
Prognostication and monitoring of mesothelioma using biomarkers: a systematic review
por: Arnold, David T, et al.
Publicado: (2017) -
Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy
por: Thieke, Christian, et al.
Publicado: (2015)